ArticleThe journal of allergy and clinical immunology. Global2025

STAT6 gain-of-function disease: p.D519N is a new disease-causing variant that responds well to dupilumab treatment.

Simran Samra et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.